Nothing Special   »   [go: up one dir, main page]

NO996132L - Vaksinesammensetninger som omfatter Heliobacter pylori FlgE- polypeptid - Google Patents

Vaksinesammensetninger som omfatter Heliobacter pylori FlgE- polypeptid

Info

Publication number
NO996132L
NO996132L NO996132A NO996132A NO996132L NO 996132 L NO996132 L NO 996132L NO 996132 A NO996132 A NO 996132A NO 996132 A NO996132 A NO 996132A NO 996132 L NO996132 L NO 996132L
Authority
NO
Norway
Prior art keywords
vaccine compositions
heliobacter pylori
flge polypeptide
helicobacter pylori
pylori flge
Prior art date
Application number
NO996132A
Other languages
English (en)
Norwegian (no)
Other versions
NO996132D0 (no
Inventor
Thomas Berglindh
Bjoern Mellgord
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996132D0 publication Critical patent/NO996132D0/no
Publication of NO996132L publication Critical patent/NO996132L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO996132A 1997-06-12 1999-12-10 Vaksinesammensetninger som omfatter Heliobacter pylori FlgE- polypeptid NO996132L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (2)

Publication Number Publication Date
NO996132D0 NO996132D0 (no) 1999-12-10
NO996132L true NO996132L (no) 2000-01-28

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996132A NO996132L (no) 1997-06-12 1999-12-10 Vaksinesammensetninger som omfatter Heliobacter pylori FlgE- polypeptid

Country Status (21)

Country Link
EP (1) EP1009764A1 (zh)
JP (1) JP2002507118A (zh)
KR (1) KR20010013699A (zh)
CN (1) CN1259960A (zh)
AR (1) AR012896A1 (zh)
AU (1) AU8048798A (zh)
BR (1) BR9810026A (zh)
CA (1) CA2293293A1 (zh)
EE (1) EE9900566A (zh)
HU (1) HUP0003164A3 (zh)
ID (1) ID23052A (zh)
IL (1) IL133144A0 (zh)
IS (1) IS5288A (zh)
NO (1) NO996132L (zh)
NZ (1) NZ501427A (zh)
PL (1) PL337503A1 (zh)
SE (1) SE9702242D0 (zh)
SK (1) SK173099A3 (zh)
TR (1) TR199903060T2 (zh)
WO (1) WO1998056816A1 (zh)
ZA (1) ZA984696B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (zh) * 2015-04-27 2015-07-22 苏州大学附属第一医院 重组绿脓杆菌鞭毛钩蛋白FlgE的用途
CN113425717B (zh) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用
CN116535472B (zh) * 2023-05-31 2024-04-30 四川大学华西医院 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用
CN118105473B (zh) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 一种预防或治疗Hp感染口服免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
BR9810026A (pt) 2000-09-19
JP2002507118A (ja) 2002-03-05
NO996132D0 (no) 1999-12-10
WO1998056816A1 (en) 1998-12-17
EP1009764A1 (en) 2000-06-21
AU8048798A (en) 1998-12-30
PL337503A1 (en) 2000-08-28
CA2293293A1 (en) 1998-12-17
IS5288A (is) 1999-12-08
CN1259960A (zh) 2000-07-12
ID23052A (id) 2000-01-20
HUP0003164A2 (hu) 2000-12-28
ZA984696B (en) 1999-01-04
HUP0003164A3 (en) 2001-10-29
TR199903060T2 (xx) 2000-09-21
EE9900566A (xx) 2000-06-15
SE9702242D0 (sv) 1997-06-12
SK173099A3 (en) 2000-06-12
AR012896A1 (es) 2000-11-22
KR20010013699A (ko) 2001-02-26
NZ501427A (en) 2000-09-29
IL133144A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
DE69529219D1 (en) Helicobacter proteine und impstoffe
NO975490L (no) Heliobacter pylori antigener og vaksinesammensetninger
DK264782A (da) Peptider som paavirker immunreguleringen og fremgangsmaaden til deres fremstilling
HK1037639A1 (en) Particles of hcv envelope proteins: use for vaccination hcv.
DK1095061T3 (da) Peptider baseret på sekvensen af humant lactoferring og deres anvendelse
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO163959C (no) Fremgangsmaate for utvinning og rensing av et polypeptid.
NO996132L (no) Vaksinesammensetninger som omfatter Heliobacter pylori FlgE- polypeptid
DK47885D0 (da) Kompositioner til brug som kosmetiske, sundhedsbevarende og kropsbeskyttende midler
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
HK1006674A1 (en) Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
NO963892L (no) Anvendelse av dimeticon for lokal antibakteriell terapi og/eller hindring og terapi i forbindelse med Helicobacter pylori (HP) assosierte syndromer og infeksjonssykdommer
FR2676068B1 (fr) Souches recombinantes immunogenes de b. anthracis - compositions immunogenes les contenant.
SE9702240D0 (sv) Vaccine compositions III
DK0952771T3 (da) Hidtil ukendte saponinpræparater og anvendelser deraf
NO20011075D0 (no) Peptidfragmenter av kolera-toksin eller enterotoksin som vaksineadjuvanser
DK421389A (da) Aminomethyl-peptider, deres fremstilling og anvendelse som laegemidler
NO830144L (no) Hydrolysert myse eller hydrolysert mysefraksjon som emulgeringsmiddel, fremgangsmaate for fremstilling derav, og bruk som matvaredressing
NO930401D0 (no) Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav
CA2247998A1 (en) Fragments of cr1 and their use
NO880080D0 (no) Fremgangsmaate for isolering og rensing av p.faliciparum cs-proteinvaksine uttrykt i rekombinant e.coli.
NO872151D0 (no) Krystallinske, aminobeskyttede aminosyrer og fremgangsmaate for deres fremstilling.
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.
DK565285A (da) Peptidvaccine eller diagnosticeringsmiddel og et polypeptid til anvendelse hertil

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application